The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Combinatorial biosynthesis of antitumor indolocarbazole compounds
Open accessAbstract
Rebeccamycin and staurosporine are natural products with antitumor properties, which belong to the family of indolocarbazole alkaloids. An intense effort currently exists for the generation of indolocarbazole derivatives for the treatment of several diseases, including cancer and neurodegenerative disorders. Here, we report a biological process based on combinatorial biosynthesis for the production of indolocarbazole compounds (or their precursors) in engineered microorganisms as a complementary approach to chemical synthesis. We have dissected and reconstituted the entire biosynthetic pathway for rebeccamycin in a convenient actinomycete host, Streptomyces albus. This task was achieved by coexpressing different combinations of genes isolated from the rebeccamycin-producing microorganism. Also, a gene ( staC ) was identified in staurosporine-producing microbes and was shown to have a key role to differentiate the biosynthetic pathways for the two indolocarbazoles. Last, incorporation of the pyrH and thal genes, encoding halogenases from different microorganisms, resulted in production of derivatives with chlorine atoms at novel positions. We produced >30 different compounds by using the recombinant strains generated in this work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Cited by
Nature's Inventory of Halogenation Catalysts: Oxidative Strategies Predominate
Vaillancourt, F. H., Yeh, E., Vosburg, D. A., Garneau-Tsodikova, S., & Walsh, C. T. (2006) · Chemical Reviews · doi:10.1021/cr050313i · Cited by 551
New aspects of natural products in drug discovery
Lam, K. S. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.04.001 · Cited by 531
Synthetic biology to access and expand nature's chemical diversity
Smanski, M. J., Zhou, H., Claesen, J., Shen, B., Fischbach, M. A., & Voigt, C. A. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.24 · Cited by 481
Natural‐Product Sugar Biosynthesis and Enzymatic Glycodiversification
Thibodeaux, C. J., Melançon, C. E., & Liu, H. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801204 · Cited by 444
A comprehensive review of glycosylated bacterial natural products
Elshahawi, S. I., Shaaban, K. A., Kharel, M. K., & Thorson, J. S. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00426d · Cited by 439
Metadata
- Authors
- Sánchez, C., Zhu, L., Braña, A. F., Salas, A. P., Rohr, J., Méndez, C., & Salas, J. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-12-29
- Volume
- 102
- Issue
- 2
- Pages
- 461-466
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2116116741
- Cited by
- 244
- References
- 1
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combinatorial biosynthesis of antitumor indolocarbazole compounds. https://app.cochat.ai/papers/10.1073/pnas.0407809102
- The paper
- Sánchez, C., Zhu, L., Braña, A. F., Salas, A. P., Rohr, J., Méndez, C., & Salas, J. A. (2005). Combinatorial biosynthesis of antitumor indolocarbazole compounds. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0407809102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.